Cygnus Biosciences

Cygnus Biosciences

A Chinese gene sequencing company.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
investor investor investor investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
*

N/A

Series C
Total Funding000k
Notes (0)
More about Cygnus Biosciences
Made with AI
Edit

Cygnus Bio is a biotechnology company specializing in advanced DNA sequencing technologies. The company serves a diverse range of clients, including research institutions, healthcare providers, and pharmaceutical companies. Operating in the rapidly growing genomics market, Cygnus Bio's core product, the Cygnus S100 DNA sequencer, is designed to deliver accurate, fast, flexible, and economical sequencing solutions. The business model is centered around the sale of its proprietary sequencing hardware and consumables, as well as offering sequencing services. Revenue is generated through direct sales, service contracts, and partnerships with key industry players. Cygnus Bio aims to revolutionize the genomics field by making high-quality DNA sequencing accessible and affordable for a broad spectrum of applications.

Keywords: DNA sequencing, biotechnology, genomics, healthcare, research, pharmaceutical, accuracy, speed, flexibility, cost-effective.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo